Recovery
Teduglutide
Also called Gattex, Revestive, ALX-0600
per administration
A human trial worked out how much to take and how often, so a dosing schedule is shown.
Licensed as a medicine in the US and EU.
Quick start
Teduglutide at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 3–4 mg per administration
- How often
- Every day
- Where
- Subcutaneous — abdomen, thigh, or upper arm Sites and rotation
- Time to steady level
- ~10 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for Teduglutide describe 3–4 mg per administration. Descriptive only, not a recommendation.
Dosing schedule
How Teduglutide is commonly stepped up, for reference only.
These are commonly-discussed research protocols shared for educational reference. This is not medical advice and is not a substitute for guidance from a qualified professional.
| Phase | Amount | Frequency | Route |
|---|---|---|---|
| Reported daily doseThe licensed once-daily amount; the dose-finding study ran 0.03–0.15 mg/kg for 21 days. | 0.05 mg/kg (about 3–4 mg for a 60–80 kg adult) | Once daily | SubQ |
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 10hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Jeppesen PB et al., Gut 2005;54:1224Subcutaneous teduglutide (ALX-0600) at 0.03–0.15 mg/kg daily for 21 days assessed for intestinal absorption in short-bowel syndrome.